iTeos Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ITOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
321 Arsenal Street, Bldg 312, Floor 3, Suite 301, Watertown, MA

Insiders trading volume in the past year

iTeos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Former 10% Owner $137M May 10, 2024
EcoR1 Capital, LLC 10%+ Owner $85.5M +$38.7M +82.6% May 14, 2025
Boxer Capital, LLC Other* $51.6M May 10, 2024
Ansbert Gadicke Former 10% Owner $27.8M -$8.32M -23% May 13, 2025
MPM BioVentures 2014, L.P. Former 10% Owner $17M -$5.08M -23% May 13, 2025
Mpm Bioventures 2018, L.P. Former 10% Owner $17M -$5.08M -23% May 13, 2025
Timothy Van Hauwermeiren Director $96.1K May 13, 2025
Michel Detheux Chief Executive Officer, Director $0 -$2.64M -100% Aug 29, 2025
Yvonne McGrath Chief Scientific Officer $0 Aug 29, 2025
Matthew Call Chief Operating Officer $0 Aug 29, 2025
David Hallal Director $0 -$1.16M -100% Aug 29, 2025
Matthew Gall Chief Financial Officer $0 Aug 29, 2025
David Feltquate Chief Medical Officer $0 Aug 29, 2025
Robert Iannone Director Jun 11, 2024
Davis Aaron I. Director Jun 11, 2024
Tony W. Ho Director Jun 11, 2024
Jill DeSimone Director Jun 11, 2024
Ann D. Rhoads Director Aug 29, 2025
Detlev Biniszkiewicz Director Jun 9, 2022
Joanne Jenkins Lager Chief Medical Officer Mar 9, 2023
David K. Lee Director Aug 29, 2025
Derek DiRocco Director Jun 13, 2023
Matthew Roden Director Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for iTeos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.